{"id":"W2113167936","doi":"10.1634/theoncologist.2011-0379","title":"Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer","year":2012,"lang":"en","type":"article","venue":"The Oncologist","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ministry of Health; Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Genentech; Canadian Cancer Society","keywords":"Medicine; Trastuzumab; Breast cancer; Regimen; Cost effectiveness; Oncology; Adjuvant; Quality of life (healthcare); Internal medicine; Quality-adjusted life year; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0153324,0.0009381173,0.001202975,0.001557404,0.0002009704,0.001595059,0.0009994559,0.001386568,0.001338443],"category_scores_gemma":[0.0618186,0.0007366419,0.002945238,0.001452006,0.0005517391,0.001525242,0.0009056493,0.001088034,0.00009335089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005598222,"about_ca_system_score_gemma":0.003135432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01296997,"about_ca_topic_score_gemma":0.008580839,"domain_scores_codex":[0.9912277,0.007324899,0.000456169,0.0003029418,0.0004257733,0.0002626007],"domain_scores_gemma":[0.956778,0.0374368,0.004055621,0.000538612,0.0008259394,0.0003649742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01307576,0.001348762,0.1127472,0.004242158,0.01480098,0.0002922718,0.0001418657,0.7995326,0.0005152365,0.002963309,0.001143017,0.04919682],"study_design_scores_gemma":[0.00412565,0.01071606,0.1036947,0.002481035,0.01528027,0.0006953843,0.0004555801,0.8455587,0.001591758,0.01254477,0.002632704,0.0002233449],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9715641,0.01605928,0.006524399,0.001698801,0.00007331504,0.0005013864,0.001836437,0.00003194547,0.001710313],"genre_scores_gemma":[0.9957774,0.001890288,0.001529446,0.00010545,0.00001832581,0.000137703,0.00046457,0.000004828468,0.00007202975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0153324,"threshold_uncertainty_score":0.08108646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1251169310672112,"score_gpt":0.4951463378981687,"score_spread":0.3700294068309575,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}